![Gerd Auffarth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerd Auffarth
Directeur/Membre du Conseil chez
OUTLOOK THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Gerd U.
Auffarth is currently Chief Executive Officer at Steinbeis-transferzentrum.
Since 2011, the Chairman of the Ophthalmology Department at Ruprecht-Karls-Universität Heidelberg.
Director at The European Society of Cataract & Refractive Surgeons since 2005.
Independent Director at Outlook Therapeutics, Inc. since 2020.
Director at International Vision Correction Research Centre since 2006.
Director at David J Apple International Laboratory For Ocular Pathology since 2012.
Director at German Ophthalmological Society since 2012.
President at Deutschsprachige Gesellschaft Fur Intraokularlinsen since 2012.
Former Independent Director at Presbia PLC.
Education includes doctorates from RWTH Aachen University (1990) and Ruprecht-Karls-Universität Heidelberg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Gerd Auffarth
| Sociétés | Poste | Début |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/04/2020 |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/04/2011 |
International Vision Correction Research Centre | Directeur/Membre du Conseil | 01/08/2006 |
The European Society of Cataract & Refractive Surgeons
 The European Society of Cataract & Refractive Surgeons Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for cataract and refractive surgeons | Directeur/Membre du Conseil | 01/09/2005 |
David J Apple International Laboratory For Ocular Pathology | Directeur/Membre du Conseil | 01/06/2012 |
German Ophthalmological Society | Directeur/Membre du Conseil | 01/09/2012 |
Steinbeis-transferzentrum | Directeur Général | - |
Deutschsprachige Gesellschaft Fur Intraokularlinsen | President | 01/03/2012 |
Anciens postes connus de Gerd Auffarth
| Sociétés | Poste | Fin |
|---|---|---|
| PRESBIA PLC | Directeur/Membre du Conseil | - |
Formation de Gerd Auffarth
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
RWTH Aachen University
 RWTH Aachen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The European Society of Cataract & Refractive Surgeons
The European Society of Cataract & Refractive Surgeons Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for cataract and refractive surgeons | Commercial Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Steinbeis-transferzentrum | |
Presbia PLC
 Presbia PLC Medical SpecialtiesHealth Technology Develops, manufactures and commercializes Presbia Flexivue Microlens | Health Technology |
International Vision Correction Research Centre | |
David J Apple International Laboratory For Ocular Pathology | |
German Ophthalmological Society | |
Deutschsprachige Gesellschaft Fur Intraokularlinsen |
